News from Parkinson's News TodayFollowNews from Parkinson's News TodaySee all of Parkinson's News Today news coverage in one place. Discover how Parkinson's News Today’s media bias informs their coverage and compare with thousands of other news outlets.Overall, we’ve indexed 110 stories from Parkinson's News Today over the past 3 months. Ground News rates Parkinson's News Today’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Parkinson's News Today’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.Follow See all of Parkinson's News Today news coverage in one place. Discover how Parkinson's News Today’s media bias informs their coverage and compare with thousands of other news outlets. Overall, we’ve indexed 110 stories from Parkinson's News Today over the past 3 months. Ground News rates Parkinson's News Today’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Parkinson's News Today’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check. Information about Parkinson's News TodayWhere is Parkinson's News Today located?Parkinson's News Today's WebsiteMedia Bias RatingsDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: UnknownLearn more about Factuality Ratings.Top Parkinson's News Today NewsParkinson's DiseaseNavigating the effects of Parkinson’s disease on speech, part 1In the first of a series, columnist Christine Scheer shares how speech difficulties due to Parkinson's disease can leave her feeling alone.See the StoryParkinson's Disease · MarylandVesalius, GSK partner to develop new Parkinson’s treatmentsVesalius Therapeutics has entered into an agreement with GSK to advance the development of new therapies for Parkinson’s disease and one other undisclosed neurodegenerative condition. Under the agreement, Vesalius will be responsible for identifying new treatment targets for the conditions, while GSK will have the option to advance promising candidates that emerge from that research. With its approach, Vesalius is changing how diseases are under…See the StoryParkinson's Disease · MarylandC-Path effort to help develop Parkinson's disease gender-equitable...The Critical Path Institute (C-Path) is launching a new initiative to advance research on how Parkinson’s disease impacts women and people across the gender spectrum. The goal is to develop treatments and technologies that take into account each person’s unique experience with the disease, leading to more equitable approaches for detecting, managing, and treating it. Launching next year, the initiative is called Gender Equitable Medicines for Pa…See the StoryLatest News StoriesTopics Most Covered by Parkinson's News TodayParkinson's DiseaseDementiaDiabetesArtificial IntelligenceDNAParkinson's DiseaseDementiaDiabetesSources Covering Similar Topicscgsentinel.comKnowridge Science ReportOxford Mailneurologylive.comMedical Device Networkcgsentinel.comKnowridge Science ReportOxford MailSuggest a sourceLooking for a source we don't already have? Suggest one here.You've scrolled to the bottom of the feed, there are no more stories.
